ClinicalTrials.gov
ClinicalTrials.gov Menu

AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01597388
Recruitment Status : Active, not recruiting
First Posted : May 14, 2012
Last Update Posted : July 26, 2017
Sponsor:
Information provided by (Responsible Party):
AstraZeneca

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : August 4, 2016
  Estimated Study Completion Date : December 12, 2017

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 September 18, 2017
(Canceled - Date Unknown)
January 15, 2018